The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
The role of the VEGF-C/VEGFR-3 axis in cancer progression
Open accessAbstract
Vascular endothelial growth factor (VEGF) receptor 3 (VEGFR-3) (also called VEGFR-3) is activated by its specific ligand, VEGF-C, which promotes cancer progression. The VEGF-C/VEGFR-3 axis is expressed not only by lymphatic endothelial cells but also by a variety of human tumour cells. Activation of the VEGF-C/VEGFR-3 axis in lymphatic endothelial cells can facilitate metastasis by increasing the formation of lymphatic vessels (lymphangiogenesis) within and around tumours. The VEGF-C/VEGFR-3 axis plays a critical role in leukaemic cell proliferation, survival, and resistance to chemotherapy. Moreover, activation of the VEGF-C/VEGFR-3 axis in several types of solid tumours enhances cancer cell mobility and invasion capabilities, promoting cancer cell metastasis. In this review, we discuss the novel function and molecular mechanism of the VEGF-C/VEGFR-3 axis in cancer progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K., Claffey, K., & Detmar, M. (2001) · Nature Medicine · doi:10.1038/84643 · Cited by 1,733
Cursiefen, C., Chen, L., Borges, L. P., Jackson, D. G., Cao, J., Radziejewski, C. H., D'Amore, P. A., Dana, M. R., Wiegand, S. J., & Streilein, J. W. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420465 · Cited by 1,059
Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics
Padera, T. P., Kadambi, A., di Tomaso, E., Carreira, C. M., Brown, E. B., Boucher, Y., Choi, N. C., Mathisen, D., Wain, J., Mark, E. J., et al. (2002) · Science · doi:10.1126/science.1071420 · Cited by 967
Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages
Maruyama, K., Ii, M., Cursiefen, C., Jackson, D. G., Keino, H., Tomita, M., Van Rooijen, N., Takenaka, H., D’Amore, P. A., Stein-Streilein, J., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23874 · Cited by 712
He, Y., Kozaki, K.-I., Karpanen, T., Koshikawa, K., Yla-Herttuala, S., Takahashi, T., & Alitalo, K. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.11.819 · Cited by 521
A Mechanism for Modulation of Cellular Responses to VEGF Activation of the Integrins
Byzova, T. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00083-6 · Cited by 438
Hoshida, T., Isaka, N., Hagendoorn, J., di Tomaso, E., Chen, Y.-L., Pytowski, B., Fukumura, D., Padera, T. P., & Jain, R. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1392 · Cited by 361
The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells
Su, J.-L., Yang, P.-C., Shih, J.-Y., Yang, C.-Y., Wei, L.-H., Hsieh, C.-Y., Chou, C.-H., Jeng, Y.-M., Wang, M.-Y., Chang, K.-J., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.02.018 · Cited by 348
Self-citationVascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma
Strizzi, L., Catalano, A., Vianale, G., Orecchia, S., Casalini, A., Tassi, G., Puntoni, R., Mutti, L., & Procopio, A. (2001) · The Journal of Pathology · doi:10.1002/path.824 · Cited by 346
Lo, H.-W., & Hung, M.-C. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602941 · Cited by 323
Self-citationWeninger, W., Partanen, T. A., Breiteneder-Geleff, S., et al. (1999) · PubMed · Cited by 254
Dias, S., Choy, M., Alitalo, K., & Rafii, S. (2002) · Blood · doi:10.1182/blood.v99.6.2179 · Cited by 250
Hanrahan, V., Currie, M. J., Gunningham, S. P., Morrin, H. R., Scott, P. A., Robinson, B. A., & Fox, S. B. (2003) · The Journal of Pathology · doi:10.1002/path.1339 · Cited by 234
Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues
Akagi, K., Ikeda, Y., Miyazaki, M., Abe, T., Kinoshita, J., Maehara, Y., & Sugimachi, K. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1396 · Cited by 230
Jüttner, S., Wiβmann, C., Jöns, T., Vieth, M., Hertel, J., Gretschel, S., Schlag, P. M., Kemmner, W., & Höcker, M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.3467 · Cited by 228
Lymphatic endothelium: a new frontier of metastasis research
Karkkainen, M. J., Mäkinen, T., & Alitalo, K. (2002) · Nature Cell Biology · doi:10.1038/ncb0102-e2 · Cited by 226
The crucial role of macrophages in lymphangiogenesis
Kerjaschki, D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26354 · Cited by 225
VEGF-A, VEGF-C, and VEGF-D in Colorectal Cancer Progression
George, M. L., Tutton, M. G., Janssen, F., Arnaout, A., Abulafi, A. M., Eccles, S. A., & Swift, R. I. (2001) · Neoplasia · doi:10.1038/sj.neo.7900186 · Cited by 223
Marschall, Z. V., Cramer, T., Höcker, M., Burde, R., Plath, T., Schirner, M., Heidenreich, R., Breier, G., Riecken, E., Wiedenmann, B., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.19578 · Cited by 189
Gombos, Z., Xu, X., Chu, C. S., Zhang, P. J., & Acs, G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1238 · Cited by 176
Chen, Z., Varney, M. L., Backora, M., Cowan, K. H., Solheim, J. C., Talmadge, J. E., & Singh, R. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0885 · Cited by 157
Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF‐C autocrine loops
Masood, R., Kundra, A., Zhu, S., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.10996 · Cited by 156
Trappen, P. O. V., Steele, D., Lowe, D. G., Baithun, S. I., Beasley, N. J. P., Thiele, W., Weich, H. A., Krishnan, J., Shepherd, J. H., Pepper, M. S., et al. (2003) · The Journal of Pathology · doi:10.1002/path.1467 · Cited by 156
SCHOPPMANN, S. F., Fenzl, A., Nagy, K., UNGER, S., Bayer, G., Geleff, S., Gnant, M., Horvat, R., Jakesz, R., & Birner, P. (2006) · Surgery · doi:10.1016/j.surg.2005.12.008 · Cited by 155
VEGF receptor expression and signaling in human bladder tumors
Wu, W., Shu, X., Hovsepyan, H., Mosteller, R. D., & Broek, D. (2003) · Oncogene · doi:10.1038/sj.onc.1206285 · Cited by 152
From angiogenesis to lymphangiogenesis
Plate, K. H. (2001) · Nature Medicine · doi:10.1038/84579 · Cited by 146
Melanoma Cell Lines Express VEGF Receptor KDR and Respond to Exogenously Added VEGF
Liu, B., Earl, H. M., Baban, D., Shoaibi, M. A., Fabra, À., Kerr, D. J., & Seymour, L. W. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2832 · Cited by 141
Yokoyama, Y., Jones, D. S., Licence, D. R., Yanaihara, A., Hastings, J. M., Holland, C. M., Emoto, M., Sakamoto, A., Sakamoto, T., Maruyama, H., et al. (2003) · PubMed · Cited by 139
Lymphatic Vessels as Targets of Tumor Therapy?
Kärpänen, T., & Alitalo, K. K. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.f37 · Cited by 130
Neuchrist, C., Erović, B. M., Handisurya, A., Fischer, M. B., Steiner, G., Hollemann, D., Gedlicka, C., Saaristo, A. M., & Burian, M. (2003) · Head & Neck · doi:10.1002/hed.10235 · Cited by 126
Zeng, Y., Opeskin, K., Baldwin, M. E., Horvath, L. G., Achen, M. G., Stacker, S. A., Sutherland, R. L., & Williams, E. D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0434 · Cited by 103
Expression of angiogenic factors and tumor progression in human neuroblastoma
Komuro, H., Kaneko, S., Kaneko, M., & Nakanishi, Y. (2001) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320100293 · Cited by 68
Koyama, Y., Kaneko, K., Akazawa, K., Kanbayashi, C., Kanda, T., & Hatakeyama, K. (2003) · Clinical Breast Cancer · doi:10.3816/cbc.2003.n.041 · Cited by 43
VEGFR-3 expression in breast cancer tissue is not restricted to lymphatic vessels
Longatto‐Filho, A., Martins, A. M., Costa, S., & Schmitt, F. C. (2005) · Pathology - Research and Practice · doi:10.1016/j.prp.2004.11.008 · Cited by 37
Cited by
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Liu, Z.-L., Chen, H.-H., Zheng, L.-L., Sun, L.-P., & Shi, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01460-1 · Cited by 1,300
Self-citationVascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
Niu, G., & Chen, X. (2010) · Current Drug Targets · doi:10.2174/138945010791591395 · Cited by 451
Lee, C., Kim, M.-J., Kumar, A., Lee, H.-W., Yang, Y., & Kim, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02249-0 · Cited by 365
Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination
Le, C. P., Nowell, C. J., Kim-Fuchs, C., Botteri, E., Hiller, J. G., Ismail, H., Pimentel, M. A., Chai, M. G., Karnezis, T., Rotmensz, N., et al. (2016) · Nature Communications · doi:10.1038/ncomms10634 · Cited by 354
Targeting the tumor microenvironment in renal cell cancer biology and therapy
Heidegger, I., Pircher, A., & Pichler, R. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00490 · Cited by 133
Metadata
- Authors
- Su, J.-L., Yen, C.-J., Chen, P.-S., Chuang, S.-E., Hong, C.-C., Kuo, I.-H., Chen, H.-Y., Hung, M.-C., & Kuo, M.-L.
- Venue
- British Journal of Cancer
- Published
- 2006-12-12
- Volume
- 96
- Issue
- 4
- Pages
- 541-545
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2099452049
- Cited by
- 252
- References
- 35
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.